Phase Forward

Provider of integrated data collection and data management solutions for clinical trials and drug safety.

Launch date

1997

Employees

Market cap

Enterprise valuation

€623m (Public information from Apr 2010)

Waltham Massachusetts (HQ)

Date	Investors	Amount	Round
Aug 2000	Atlas Venture HLM Venture Partners Thomas Weisel Partners Sprout Group Bioventures Investors Pacific Venture Group SV Health Investors	$25.0m	Late VC
Jan 2001	New Enterprise Associates	N/A	-
Jul 2004	N/A	N/A	IPO
Apr 2010	Oracle	$685m Valuation: $685m	Acquisition
Total Funding		€22.7m

ACQUISITION by Phase Forward Apr 2009

Recent News about Phase Forward